65,437 trials
Patient Engagement · Medication Optimization · Heart Failure With Reduced Ejection Fraction
Primary: Percent of Participants Who Experienced an Initiation or Intensification of Their Guideline-Directed Medical Therapy (GDMT) — 29.7; 49.0 percentage of participants
Head and Neck Neoplasms
Primary: Change in Functional Assessment of Cancer Therapy - Head and Neck (FACT - H&N) — 3.1; 5.3 score on a scale
Malignant Neoplasm of Breast
Primary: Percentage of Participants With Progression Free Survival (PFS) at Month 12 — 84.1; 79.8 Percentage of participants
Polymyositis · Dermatomyositis · Autoimmune Necrotizing Myopathy
Primary: Number of Participants Achieving International Myositis Assessment and Clinical Studies Definition of Improvement (IMACS DOI) at Week 24 Without Rescue — 42; 31…
Health Communication
Primary: Mean CD4 Count — 321.5; 418; 390.5 Cells/mm^3 — p=0.283
Plasmodium Falciparum Malaria
Primary: PCR-Corrected ACPR at Day 28 — 95; 99; 99 percentage of subjects
Fuchs' Corneal Endothelial Dystrophy (FCED)
Primary: Incidence and Severity of Ocular TEAEs. — 3; 6; 1; 1 Participants
Falciparum Malaria
Primary: Percentage of Subjects With PCR-corrected Adequate Clinical and Parasitological Response (ACPR) on Day 28 — 99.2; 98.1 percentage of subjects — p=0.106
Sinus Node Dysfunction
Primary: The Absolute Change in the Proportion of Subjects Diagnosed With SND Before and After Intervention — 368; 409 Participants — p=<0.00001
Diabetes Mellitus, Type 2
Primary: Overnight Respiratory Exchange Ratio — 0.832; 0.887 ratio
HSV-2 Infection · PreTerm Birth · Pregnancy Complications
Primary: Number of Participants With Preterm Delivery — 100; 83; 247; 5407 Participants
NYHA Class III Heart Failure · NYHA Class IV Heart Failure
Primary: Peak VO2 — 15.28; 14.79 ml/kg/min — p=0.975
Ovarian Cancer
Primary: Feasibility of the Accelerometer + Social Support + Gamification — 24; 5 Participants
Ulcerative Colitis
Primary: Number of Participants With Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs) — 154; 626; 39; 147 Participants
Spinal Cord Injury · Constipation · Fecal Incontinence
Primary: Baseline Motility (Anorectal Sensation and Strength) Characteristics — 105; 34.4; 30; 77.9 mmHg